Rising Biosciences (Rising Biosciences) Dividend Payout Ratio : 0.00 (As of . 20)

View and export this data going back to . Start your Free Trial

What is Rising Biosciences Dividend Payout Ratio?

Rising Biosciences's dividend payout ratio for the months ended in . 20 was 0.00.

The historical rank and industry rank for Rising Biosciences's Dividend Payout Ratio or its related term are showing as below:

RBII's Dividend Payout Ratio is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.33
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-06-15), the Dividend Yield % of Rising Biosciences is 0.00%.

Rising Biosciences's Dividends per Share for the months ended in . 20 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Rising Biosciences Dividend Payout Ratio Historical Data

The historical data trend for Rising Biosciences's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rising Biosciences Dividend Payout Ratio Chart

Rising Biosciences Annual Data

Trend

Dividend Payout Ratio

Rising Biosciences Quarterly Data

Dividend Payout Ratio

Competitive Comparison of Rising Biosciences's Dividend Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Rising Biosciences's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rising Biosciences's Dividend Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rising Biosciences's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Rising Biosciences's Dividend Payout Ratio falls into.

Rising Biosciences Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Rising Biosciences's Dividend Payout Ratio for the fiscal year that ended in . 20 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: . 20 )	/	EPS without NRI (A: . 20 )
	=		/
	=	N/A

Rising Biosciences's Dividend Payout Ratio for the quarter that ended in . 20 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: . 20 )	/	EPS without NRI (Q: . 20 )
	=		/
	=	N/A

Rising Biosciences (GREY:RBII) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Rising Biosciences Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Rising Biosciences's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Rising Biosciences (Rising Biosciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rising Biosciences Inc (GREY:RBII) » Definitions » Dividend Payout Ratio

Traded in Other Exchanges

N/A

Address

1180 Cleveland Road, Sandusky, OH, USA, 44870

Website

http://www.risingbiosciences.com

Rising Biosciences Inc is a United States-based company engaged in research and development activities. It is focused on oral and topical cannabis and non-cannabis based pharmaceuticals. The company seeks to address the market demand for the treatment of the danger of opiates, whose long-term effects can include liver damage, addiction and brain damage due to hypoxia, resulting from respiratory depression, among other complications.